Ireland Information and Enquiries
On 1st October 2025, Neopharmed Gentili Completed Acquisition of European ORLADEYO Business from BioCryst Pharmaceuticals. You can read the press release here.
Medicines in Ireland
The content on this page is intended for members of the public. Our current prescription medicines are listed below.

ORLADEYO® (berotralstat)
This medicine is subject to additional monitoring. For complete information, consult the Summary of Product Characteristics (SmPC) and the Notice on ema.europe.eu.
Customer Assistance
Medical Information
For medical information:
medinfoeurope@biocryst.com or
+353 1 699 4405
Adverse events/product complaints
Adverse events should be reported to BioCryst Ireland Ltd., a Neopharmed Gentili company, at:
medinfoeurope@biocryst.com or
+353 1 699 4405
General enquiries
For general enquiries:
EnquiriesIreland@neopharmedgentili.com
BioCryst Ireland Limited (office)
Block 4,
Harcourt Centre, Harcourt Road,
Dublin 2
D02 HW77
Ireland
+353 (1) 477 3087
Disclosures
Healthcare professionals: BioCryst Ireland, a Neopharmed Gentili company, complies with all transparency obligations imposed on pharmaceutical companies. We publish our links of interest with health professionals and organisations. Please visit https://www.transferofvalue.ie/ToVData/BCU for more information.